Skip to main content
. 2023 May 16;67(6):e00120-23. doi: 10.1128/aac.00120-23

TABLE 4.

Outcomes of patients in the oral antibiotic group, stratified by relative antibiotic dosing

Characteristic Usual (n = 49) Low (n = 9) High (n = 8) Total (n = 66)
Oral antibiotic agent
 Amoxicillin 12 (24.5%) 0 5 (62.5%) 17 (25.8%)
 Amoxicillin-clavulanate 16 (32.7%) 1 (11.1%) 0 17 (25.8%)
 Cefadroxil 7 (14.3%) 3 (33.3%) 2 (25.0%) 12 (18.2%)
 Cefdinir 9 (18.4%) 0 1 (12.5%) 10 (15.2%)
 Cephalexin 1 (2.0%) 4 (44.4%) 0 5 (7.6%)
 Clindamycin 1 (2.0%) 1 (11.1%) 0 2 (3.0%)
 Doxycycline 1 (2.0%) 0 0 1 (1.5%)
 Penicillin 2 (4.1%) 0 0 2 (3.0%)
30-day treatment failure 8 (16.3%) 4 (44.4%) 1 (12.5%) 13 (19.7%)
 30-day mortality 1 (2.0%) 2 (22.2%) 0 3 (4.5%)
 30-day readmission 5 (10.2%) 1 (11.1%) 0 6 (9.1%)
 30-day relapse 3 (6.1%) 1 (11.1%) 1 (12.5%) 5 (7.6%)
90-day treatment failure 11 (22.4%) 4 (44.4%) 2 (25.0%) 17 (25.8%)
 90-day mortality 2 (4.1%) 2 (22.2%) 0 4 (6.1%)
 90-day readmission 7 (14.3%) 1 (11.1%) 1 (12.5%) 9 (13.6%)
 90-day relapse 3 (6.1%) 1 (11.1%) 2 (25.0%) 6 (9.1%)